Matches in Wikidata for { <http://www.wikidata.org/entity/Q91498186> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- Q91498186 description "article scientifique publié en 2019" @default.
- Q91498186 description "artículu científicu espublizáu en payares de 2019" @default.
- Q91498186 description "im November 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91498186 description "scientific article published on 27 November 2019" @default.
- Q91498186 description "wetenschappelijk artikel" @default.
- Q91498186 description "наукова стаття, опублікована 27 листопада 2019" @default.
- Q91498186 name "R-GEM-Lenalidomide versus R-GEM-P as second-line treatment of diffuse large B-cell lymphoma: results of the UK NRCI phase II randomised LEGEND trial" @default.
- Q91498186 name "R-GEM-Lenalidomide versus R-GEM-P as second-line treatment of diffuse large B-cell lymphoma: results of the UK NRCI phase II randomised LEGEND trial" @default.
- Q91498186 type Item @default.
- Q91498186 label "R-GEM-Lenalidomide versus R-GEM-P as second-line treatment of diffuse large B-cell lymphoma: results of the UK NRCI phase II randomised LEGEND trial" @default.
- Q91498186 label "R-GEM-Lenalidomide versus R-GEM-P as second-line treatment of diffuse large B-cell lymphoma: results of the UK NRCI phase II randomised LEGEND trial" @default.
- Q91498186 prefLabel "R-GEM-Lenalidomide versus R-GEM-P as second-line treatment of diffuse large B-cell lymphoma: results of the UK NRCI phase II randomised LEGEND trial" @default.
- Q91498186 prefLabel "R-GEM-Lenalidomide versus R-GEM-P as second-line treatment of diffuse large B-cell lymphoma: results of the UK NRCI phase II randomised LEGEND trial" @default.
- Q91498186 P1433 Q91498186-D7267133-3E2A-415A-84E3-5259AC1CC65C @default.
- Q91498186 P1476 Q91498186-FD05AB50-646E-4258-B427-931B8BC0E649 @default.
- Q91498186 P2093 Q91498186-03B0C0C4-0775-45B1-B899-BF93D51BFDE3 @default.
- Q91498186 P2093 Q91498186-04A34158-D825-4BF6-A06F-B90BBA58C352 @default.
- Q91498186 P2093 Q91498186-15CF618C-CDDA-4B34-967D-08E4BB351108 @default.
- Q91498186 P2093 Q91498186-7099329C-79B9-4462-80FB-1089A45FB682 @default.
- Q91498186 P2093 Q91498186-8B7D3FED-52D7-4D7E-B5B8-01D3650E6E3D @default.
- Q91498186 P2093 Q91498186-93EC4D9A-789F-422D-8A0B-069DD6628F54 @default.
- Q91498186 P2093 Q91498186-A0632028-126E-4900-BF2F-D94DEC9B8839 @default.
- Q91498186 P2093 Q91498186-A2E02209-B15F-4BF7-A04A-7D59D7943513 @default.
- Q91498186 P2093 Q91498186-A45A4D0C-775D-4631-B141-4ECAE9089349 @default.
- Q91498186 P2093 Q91498186-DB4C67A2-DBBA-495C-A2C8-141EA0D639F5 @default.
- Q91498186 P2093 Q91498186-DDB65EA7-2551-4277-8FE5-97610AEAE3EE @default.
- Q91498186 P2093 Q91498186-E430740B-6344-4ACF-A483-E4708FEFE3EC @default.
- Q91498186 P2093 Q91498186-E5C6FFC7-6018-47AF-A366-9E8275D09E24 @default.
- Q91498186 P2093 Q91498186-F961C826-3394-42BD-85BA-33C672239EC2 @default.
- Q91498186 P304 Q91498186-1BAE1695-2229-48A2-94CF-08AE2D190ADE @default.
- Q91498186 P31 Q91498186-5F8E3C9D-DA02-435B-B913-538ED73114EF @default.
- Q91498186 P356 Q91498186-49A514D9-2964-4055-9BB8-87E237BA4923 @default.
- Q91498186 P433 Q91498186-C15196BA-7323-4A57-B157-D2C54A1E76AF @default.
- Q91498186 P478 Q91498186-6AC89E22-D51F-48BF-8382-0C09590D17D8 @default.
- Q91498186 P50 Q91498186-3D7BBFE1-8367-4AE3-8939-B2F40B9C3289 @default.
- Q91498186 P50 Q91498186-76095455-E5E5-44EE-BF68-7B5720A1E6DB @default.
- Q91498186 P577 Q91498186-4872CAAA-A05C-43F6-BBA9-21729F5A3493 @default.
- Q91498186 P698 Q91498186-A3AF2711-9B25-4BB2-A79F-727234C783AD @default.
- Q91498186 P921 Q91498186-159C4AFC-3996-4028-9911-6B58F2A60B71 @default.
- Q91498186 P921 Q91498186-D47821DE-3E72-4620-BA46-7B70FA148AAB @default.
- Q91498186 P921 Q91498186-F2E50E08-7A3A-44E6-8417-E334A0050073 @default.
- Q91498186 P356 S00277-019-03842-4 @default.
- Q91498186 P698 31776726 @default.
- Q91498186 P1433 Q15766509 @default.
- Q91498186 P1476 "R-GEM-Lenalidomide versus R-GEM-P as second-line treatment of diffuse large B-cell lymphoma: results of the UK NRCI phase II randomised LEGEND trial" @default.
- Q91498186 P2093 "Andrea Kühnl" @default.
- Q91498186 P2093 "Andrew Wotherspoon" @default.
- Q91498186 P2093 "Bijal Patel" @default.
- Q91498186 P2093 "Clare Peckitt" @default.
- Q91498186 P2093 "David Cunningham" @default.
- Q91498186 P2093 "Ian Chau" @default.
- Q91498186 P2093 "Imene Zerizer" @default.
- Q91498186 P2093 "Marian P Macheta" @default.
- Q91498186 P2093 "Nicola Valeri" @default.
- Q91498186 P2093 "Rod Johnson" @default.
- Q91498186 P2093 "Ruwaida Begum" @default.
- Q91498186 P2093 "Sarah Barton" @default.
- Q91498186 P2093 "Shankaranarayana Paneesha" @default.
- Q91498186 P2093 "Yong Du" @default.
- Q91498186 P304 "105-112" @default.
- Q91498186 P31 Q13442814 @default.
- Q91498186 P356 "10.1007/S00277-019-03842-4" @default.
- Q91498186 P433 "1" @default.
- Q91498186 P478 "99" @default.
- Q91498186 P50 Q110165834 @default.
- Q91498186 P50 Q42388605 @default.
- Q91498186 P577 "2019-11-27T00:00:00Z" @default.
- Q91498186 P698 "31776726" @default.
- Q91498186 P921 Q2626074 @default.
- Q91498186 P921 Q42824440 @default.
- Q91498186 P921 Q4833719 @default.